Clinical Trial Update: The Effect of Testosterone Replacement on the High Density Lipoprotein Cholesterol Subgroups [Phase 4]

View source ↗

Summary

Phase 4 trial update examining the effect of testosterone replacement on HDL cholesterol subgroups in men with secondary hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadism

Drugs mentioned

• TESTOSTERONE (testosterone)

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Secondary Hypogonadism | Phase 4 | Status: COMPLETED